145 related articles for article (PubMed ID: 36287282)
1. Model-free dynamic contrast-enhanced MRI analysis: differentiation between active tumor and necrotic tissue in patients with glioblastoma.
Bressler I; Ben Bashat D; Buchsweiler Y; Aizenstein O; Limon D; Bokestein F; Blumenthal TD; Nevo U; Artzi M
MAGMA; 2023 Feb; 36(1):33-42. PubMed ID: 36287282
[TBL] [Abstract][Full Text] [Related]
2. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI.
Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2016 May; 127(3):515-24. PubMed ID: 26754857
[TBL] [Abstract][Full Text] [Related]
4. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images.
Sengupta A; Agarwal S; Gupta PK; Ahlawat S; Patir R; Gupta RK; Singh A
Eur J Radiol; 2018 Sep; 106():199-208. PubMed ID: 30150045
[TBL] [Abstract][Full Text] [Related]
5. Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Spanakis M; Kontopodis E; Van Cauter S; Sakkalis V; Marias K
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):529-47. PubMed ID: 27647272
[TBL] [Abstract][Full Text] [Related]
6. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
7. Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging.
Mehrabian H; Chandrana C; Pang I; Chopra R; Martel AL
Eur Radiol; 2012 Aug; 22(8):1735-47. PubMed ID: 22752523
[TBL] [Abstract][Full Text] [Related]
8. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
9. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between glioblastoma and primary CNS lymphoma: application of DCE-MRI parameters based on arterial input function obtained from DSC-MRI.
Kang KM; Choi SH; Chul-Kee P; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Yun TJ; Kim JH; Sohn CH
Eur Radiol; 2021 Dec; 31(12):9098-9109. PubMed ID: 34003350
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling of dynamic contrast-enhanced MRI using a reference region and input function tail.
Ahmed Z; Levesque IR
Magn Reson Med; 2020 Jan; 83(1):286-298. PubMed ID: 31393033
[TBL] [Abstract][Full Text] [Related]
12. Automatic segmentation of invasive breast carcinomas from dynamic contrast-enhanced MRI using time series analysis.
Jayender J; Chikarmane S; Jolesz FA; Gombos E
J Magn Reson Imaging; 2014 Aug; 40(2):467-75. PubMed ID: 24115175
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation.
Fedorov A; Fluckiger J; Ayers GD; Li X; Gupta SN; Tempany C; Mulkern R; Yankeelov TE; Fennessy FM
Magn Reson Imaging; 2014 May; 32(4):321-9. PubMed ID: 24560287
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Contrast-Enhanced Perfusion MRI of High Grade Brain Gliomas Obtained with Arterial or Venous Waveform Input Function.
Filice S; Crisi G
J Neuroimaging; 2016; 26(1):124-9. PubMed ID: 25923172
[TBL] [Abstract][Full Text] [Related]
16. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
Hsu YH; Ferl GZ; Ng CM
Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
[TBL] [Abstract][Full Text] [Related]
17. Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer.
Ikoma Y; Kishimoto R; Tachibana Y; Omatsu T; Kasuya G; Makishima H; Higashi T; Obata T; Tsuji H
Magn Reson Imaging; 2020 Feb; 66():185-192. PubMed ID: 31487532
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
[TBL] [Abstract][Full Text] [Related]
19. Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
Larsson C; Groote I; Vardal J; Kleppestø M; Odland A; Brandal P; Due-Tønnessen P; Holme SS; Hope TR; Meling TR; Fosse E; Emblem KE; Bjørnerud A
Magn Reson Imaging; 2020 May; 68():106-112. PubMed ID: 32004711
[TBL] [Abstract][Full Text] [Related]
20. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
